Non-Starch Polysaccharide Enzymes Market By Enzyme Type (Xylanase, β-Glucanase, β-Mannanase, Cellulase, Pectinase, Multi-Enzyme NSP Systems); By Animal Application (Poultry, Swine, Aquaculture); By Geography, Segment Revenue Estimation, Forecast, 2026-2032

Non-Starch Polysaccharide Enzymes Market: Feed Economics, Enzyme Technology, Application Trends, Competitive Landscape and Regional Analysis

The Global Non-Starch Polysaccharide Enzymes Market was valued at USD 1.18 billion in 2025 and is projected to reach USD 1.91 billion by 2032, expanding at a CAGR of 7.2% during 2026–2032, according to Strategic Market Research.

 

The Non-Starch Polysaccharide Enzymes Market comprises enzyme preparations designed to break down fibrous carbohydrates in plant-derived raw materials that monogastric animals cannot efficiently digest with their own endogenous enzymes. The principal commercial NSP-degrading enzymes include xylanase, β-glucanase, β-mannanase, cellulase and pectinase, used individually or as multi-enzyme combinations. In commercial animal nutrition, their importance comes from improving the utilization of corn, wheat, barley, soybean meal, DDGS, bran and other plant ingredients rather than merely acting as general digestive additives.

 

NSPs affect feed value in two major ways. Soluble fractions such as arabinoxylans and β-glucans can increase intestinal viscosity, restricting movement of digestive enzymes and nutrients, while insoluble NSP structures form plant cell walls that physically encapsulate starch, protein and other nutrients. Xylanases, glucanases and related carbohydrases partially dismantle those structures, reducing viscosity and releasing nutrients that would otherwise pass through the digestive tract with limited utilization. Recent research is also examining whether the resulting oligosaccharides can influence microbial fermentation and gut health, making NSP enzymes increasingly important as both feed-efficiency and intestinal-nutrition tools.

 

Key Report Takeaways

• Leading Enzyme Type: Xylanase led the enzyme-type segment with a 31.0% share, valued at approximately USD 0.37 billion in 2025, and is expected to grow at a 7.0% CAGR.

• Fastest-Growing Enzyme Type: Multi-Enzyme NSP Systems accounted for 15.0% of the market, or USD 0.18 billion in 2025, and are projected to expand at the fastest 8.6% CAGR.

• Leading Animal Application: Poultry dominated animal applications with a 61.0% share, valued at approximately USD 0.72 billion in 2025, and is projected to grow at a 7.0% CAGR.

• Fastest-Growing Animal Application: Aquaculture represented 11.0% of the market, or approximately USD 0.13 billion in 2025, and is expected to record the highest application CAGR of 9.0%.

• Leading Region: Asia Pacific held the largest regional share at 38.0%, equivalent to approximately USD 0.45 billion in 2025, and is projected to expand at an 8.1% CAGR.

• Europe: Europe accounted for 25.0% of the market, valued at approximately USD 0.30 billion in 2025, with an expected 6.4% CAGR through 2032.

• North America: North America represented 23.0% of the market, or approximately USD 0.27 billion in 2025, and is projected to grow at a 6.5% CAGR.

• Latin America: Latin America accounted for 8.0% of the market, valued at approximately USD 0.09 billion in 2025, and is expected to expand at a 7.6% CAGR.

• Middle East & Africa: The Middle East & Africa represented 6.0% of the market, or approximately USD 0.07 billion in 2025, with a projected 7.0% CAGR during 2026–2032.

 

Why Is Demand for NSP Enzymes Increasing in Commercial Feed Production?

Feed economics are the central demand driver. In modern poultry and swine production, small improvements in nutrient utilization become commercially important because producers purchase enormous quantities of grain and protein meals. USDA projected U.S. feed-and-residual use of corn, sorghum, barley and oats at approximately 159.2 million metric tons in 2025/26, with corn representing more than 97% of the four-grain total. This scale means technologies that allow formulators to obtain more metabolizable energy from grain-based diets can create meaningful savings even without dramatically changing animal growth rates.

 

The same effect is magnified in China. China produced approximately 342.25 million tons of industrial feed in 2025, an increase of 8.6%, while compound feed production rose 8.8%. Swine-feed output increased 15.6%, meat-poultry feed 3.5% and layer feed 1.4%. These are particularly relevant statistics for NSP enzymes because pigs and poultry constitute their core commercial end users. Large-scale feed mills processing hundreds of millions of tons of corn, soybean meal, wheat and alternative ingredients provide a substantial addressable volume for xylanase, β-mannanase, β-glucanase and multi-carbohydrase products.

 

Another important driver is the growing use of lower-cost or locally available alternative feed ingredients. Wheat bran, rice bran, DDGS, soybean hulls, sunflower meal, rapeseed meal and other processing by-products can lower ration cost but frequently contain higher or structurally different NSP fractions than conventional corn-soybean diets. Recent poultry research specifically notes that increasing feed costs encourage the incorporation of grain by-products such as DDGS, wheat bran and rice bran, but their higher NSP content can constrain nutrient utilization unless appropriately managed. This creates a commercial role for substrate-specific enzyme programs rather than a single standardized enzyme dose across every feed formulation.

 

Recent studies also strengthen the economic case for multi-substrate strategies. A 2025 study involving 384 broilers found that β-mannanase and a xylanase-plus-β-glucanase preparation affected NSP degradation, energy utilization and gastrointestinal conditions in wheat-based diets. Importantly, however, the study also found that combining enzymes did not automatically improve every performance variable beyond the results achieved by individual supplementation. This distinction is important commercially: future growth is likely to come from more precise enzyme-to-substrate matching rather than simply adding increasing numbers of enzymes to a formulation.

 

Which Enzyme Type Is Leading the Market?

Xylanase is the leading NSP-enzyme category from a commercial-use perspective. Arabinoxylans are widespread in cereal grains, including wheat and corn, while poultry and pigs have limited endogenous capacity to break them down. Academic literature identifies xylanase as the most widely used NSPase in poultry nutrition, reflecting its broad compatibility with cereal-based diets. Large suppliers also position xylanase as a core carbohydrase platform rather than a niche product.

 

Its commercial advantage is its ability to work across multiple feed-grain systems. Novonesis markets RONOZYME WX for wheat, corn, barley, rye, triticale, sorghum, millet, brown rice and grain by-products, while IFF's Danisco Xylanase targets arabinoxylans to reduce their negative nutritional effects. Consequently, xylanase has a wider feed-formulation addressable base than β-glucanase, which is particularly relevant to barley- and oat-rich diets, or β-mannanase, which has a more specific relationship with mannans from soybean meal and other plant proteins.

 

β-mannanase is one of the faster-developing specialized categories. Soybean meal remains a core protein source in commercial poultry and swine diets, and β-mannans are among its relevant anti-nutritional carbohydrate components. BASF's Natupulse TS is designed specifically around this substrate opportunity, while current research is assessing β-mannanase alone and alongside xylanase and β-glucanase. This creates a strong commercial rationale for β-mannanase in regions where corn-soybean meal formulations dominate.

 

Multi-enzyme NSP systems are becoming more important where diets contain several grains, protein meals and by-products. They may combine xylanase, β-glucanase, cellulase, mannanase or pectinase to attack several cell-wall structures simultaneously. Novonesis' RONOZYME MultiGrain combines xylanase, glucanase and cellulase, while Kemin offers formulations containing several NSP-active enzymes. This segment is particularly relevant in markets where feed formulators regularly switch raw materials according to commodity prices.

 

Which Animal Application Leads Demand?

Poultry represents the strongest application for NSP-degrading enzymes, supported by its enormous feed throughput, short production cycles and high sensitivity to feed conversion economics. USDA reported U.S. broiler production of about 46.5 billion pounds in 2024 and forecast approximately 47.1 billion pounds for 2025. China produced 28.37 million tons of poultry meat in 2025, up 6.7%. Both markets therefore operate industrial poultry systems in which tiny changes in feed conversion or dietary energy extraction can translate into substantial feed-volume effects.

 

Poultry also provides a particularly clear biological case for NSP enzymes because soluble NSP-driven viscosity can interfere with digestion in the relatively short avian gastrointestinal tract. Controlled studies continue to examine xylanase, xylanase-β-glucanase and broader NSPase systems in energy-reduced or higher-fiber diets. In one 2025 study involving 400 broilers, xylanase-containing treatments reduced ileal viscosity and increased xylo-oligosaccharide concentrations relative to an unsupplemented low-energy, high-NSP diet.

 

Swine is the second major application and an important expansion area. USDA projected U.S. pork production at approximately 28.5 billion pounds in 2025, while China produced 59.38 million tons of pork and slaughtered around 719.7 million pigs in the same year. Swine diets increasingly incorporate DDGS, wheat bran, soybean hulls and other fibrous ingredients, making degradation of arabinoxylans and mannans economically relevant.

 

A 2025 North Carolina State University study involving 160 nursery pigs evaluated xylanase and β-mannanase in diets using DDGS or soybean hulls plus wheat bran. Research of this type illustrates where the swine market is heading: NSP enzymes are being evaluated not merely as generic digestibility enhancers, but as formulation tools that could permit more effective use of specific fibrous raw materials.

 

Aquaculture remains a smaller but strategically relevant opportunity as fish diets incorporate more plant proteins to supplement or replace marine-origin ingredients. However, poultry and swine are likely to remain the commercial center of NSP-enzyme demand because their feed volumes, grain dependency and enzyme adoption infrastructure are much more developed.

 

What Technology Trends Are Reshaping NSP Enzymes?

The technology race is shifting from simply discovering additional carbohydrases toward creating enzymes that work reliably under commercial processing conditions. Feed pelleting exposes enzymes to moisture, pressure and elevated temperatures, while gastrointestinal conditions introduce changing pH and proteolytic activity. Heat stability therefore has direct commercial value because an enzyme that performs well in laboratory assays but loses activity during feed manufacturing offers limited economic benefit.

 

Suppliers are addressing this through thermostable granulates, liquid post-pelleting systems and engineered enzyme molecules. BASF specifies dry and liquid formulations for its NSP portfolio and differentiates application depending on pelleting conditions. AB Enzymes describes ECONASE XT as an intrinsically thermostable xylanase designed for pig and poultry feeds, while IFF's Danisco Xylanase is positioned for stability through commercial feed processing.

 

A second technology trend is precision substrate targeting. Rather than treating dietary fiber as one uniform material, developers increasingly distinguish arabinoxylans, β-glucans, mannans, cellulose and pectins according to ingredient composition. Corn, wheat, barley, soybean meal and DDGS can therefore require different enzyme strategies. The competitive advantage is moving toward libraries of enzyme activities, feed-ingredient analytics and formulation models capable of recommending the correct product and dose for each ration.

 

A third trend is the transition from single enzymes toward designed enzyme combinations, but research suggests the industry must be selective. The value of combinations depends on whether relevant substrates are actually present. Evidence that additional enzymes do not always create additive performance improvements means feed producers are likely to demand stronger ingredient-specific validation. This will favor suppliers capable of conducting feed analysis and in-vivo validation rather than companies competing primarily on enzyme concentration or low price.

 

What Factors Restrain Market Expansion?

The greatest restraint is variability in enzyme response. NSP is not a single substrate. Fiber chemistry varies by crop, variety, processing method, growing conditions and inclusion rate. A xylanase optimized for one arabinoxylan structure may not perform identically when the grain mix changes, while mannanase value depends heavily on the concentration and accessibility of mannans in the diet.

 

Feed manufacturing creates an additional challenge. Earlier research demonstrated substantial activity losses for some carbohydrase blends following high-temperature processing, illustrating why thermostability remains an ongoing development priority. Modern formulations have improved considerably, but commercial performance still depends on conditioning temperature, residence time, moisture, formulation and whether enzymes are incorporated before or after pelleting.

 

Another restraint is diminishing marginal benefit from enzyme stacking. Recent broiler research found that xylanase-plus-β-glucanase and β-mannanase each produced beneficial responses, but combining them did not uniformly generate an additional improvement in feed conversion. These results challenge the assumption that broader cocktails are automatically better and increase the importance of cost-per-unit-of-response calculations.

 

Finally, suppliers must prove consistency across commercially relevant diets. Feed mills make purchasing decisions around repeatable economic outcomes, not merely enzyme activity measured under ideal conditions. Variations in grain quality and the rapid substitution of ingredients when commodity prices change can therefore weaken predictable returns and slow adoption among price-sensitive producers.

 

Why Are the United States and China Particularly Important?

United States

The United States is one of the most commercially attractive markets for NSP enzymes because its poultry and swine industries operate at enormous scale and are closely linked to abundant corn and soybean production. USDA projected 6.1 billion bushels of corn for feed and residual use in 2025/26, while commercial broiler output was expected near 47 billion pounds and pork production around 28.5 billion pounds in 2025. These feed and animal-production volumes directly support demand for xylanases and β-mannanases suited to corn-soybean diets.

 

The U.S. opportunity is also evolving as DDGS, soybean hulls, wheat middlings and other by-products enter feed formulations. NSP enzymes allow nutritionists to pursue lower-cost formulation strategies while attempting to preserve metabolizable energy and feed conversion. The country is also an important research and product-development base; recent swine studies from North Carolina State University demonstrate continuing work on xylanase and mannanase combinations in fibrous diets.

 

China

China has an even larger industrial-feed volume. Total industrial feed production reached approximately 342.25 million tons in 2025, with swine feed output rising 15.6%. China also produced 59.38 million tons of pork and 28.37 million tons of poultry meat, while corn production reached 301.24 million tons. This combination of huge livestock populations, feed production and grain consumption provides an unusually large operating base for NSP-enzyme applications.

 

The country's feed strategy also strengthens the case for enzymes. China is emphasizing feed efficiency, domestic grain security and greater utilization of diverse feed resources. In Hubei alone, industrial feed production reached 16.31 million tons in 2025, up 17.1%, and provincial authorities specifically highlighted efficient utilization of non-grain feed resources and feed-saving technologies. At national level, increased use of domestic corn, downgraded wheat and other available grain streams increases the commercial importance of technologies that help formulators adapt nutritional value across changing raw-material mixes.

 

Other Important Countries

Brazil is important because of its enormous poultry, pork, corn and soybean production complex; European markets such as Germany, France and the United Kingdom have mature feed-additive adoption and substantial use of wheat- and barley-based diets, supporting xylanase and β-glucanase demand. India combines a rapidly expanding poultry industry with highly variable raw-material formulations involving maize, soybean meal, rice by-products and millet, favoring multi-enzyme systems. Japan and South Korea represent technically sophisticated but comparatively smaller feed markets, while Indonesia and other Southeast Asian countries offer opportunities where corn, rice by-products, palm-derived meals and imported soybean meal create complex NSP profiles.

 

How Is Competition Developing Among Leading Companies?

The competitive landscape is led by companies with extensive fermentation capabilities, enzyme libraries, formulation expertise and global feed-industry distribution. Important participants include Novonesis, BASF, IFF/Danisco Animal Nutrition & Health, AB Enzymes/AB Vista, Adisseo, Kemin Industries and Huvepharma.

 

Novonesis, formed from the combination of Novozymes and Chr. Hansen, is particularly well positioned because its NSP portfolio spans both single-target and multi-component carbohydrases. RONOZYME WX addresses xylans across several cereal grains, RONOZYME MultiGrain combines xylanase, glucanase and cellulase, while RONOZYME VP targets complex cell-wall structures in protein-rich feed ingredients using glucanase and pectinase activities. This portfolio enables Novonesis to compete across corn-, wheat-, barley- and alternative-protein-based formulations rather than depending on one substrate.

 

BASF competes through an unusually clear substrate-specific NSP platform. Natugrain TS combines xylanase and β-glucanase for cereal NSPs, whereas Natupulse TS targets β-mannans associated with soybean meal and other plant protein ingredients. BASF has also expanded fermentation capacity at Ludwigshafen to support enzyme supply. Its competitive strategy is therefore moving toward combinations that cover both cereal fiber and soybean-derived NSPs while giving feed manufacturers dry and liquid application alternatives.

 

The company historically associated with DuPont/Danisco now competes in this field through IFF's Danisco Animal Nutrition & Health business. Its portfolio includes Danisco Xylanase as well as multi-enzyme systems such as Axtra XAP and established products including Avizyme and Porzyme. Danisco Xylanase specifically targets arabinoxylans and is offered in dry and liquid forms, giving IFF a strong position in cereal-based poultry and swine diets.

 

The competitive race is increasingly about three capabilities: thermostability, substrate coverage and measurable feed-cost reduction. Novonesis has breadth across cereal and protein-feed NSPs; BASF is building complementary xylanase/glucanase/mannanase positioning; IFF/Danisco combines xylanase with broader multi-enzyme nutrition systems. AB Enzymes/AB Vista competes strongly around thermostable xylanase technology, while Kemin emphasizes multi-enzyme solutions capable of handling variable feed ingredients.

 

This means NSP enzymes are becoming less of a commodity additive market and more of a feed-formulation technology competition. The supplier that can demonstrate that its enzyme remains active through manufacturing, matches the actual NSP profile of a customer's diet and allows a measurable reduction in ration cost has an advantage over one selling solely on stated enzyme activity.

 

Market Outlook

The long-term opportunity for NSP enzymes rests less on simply producing more meat and more on the need to obtain greater nutritional value from every ton of feed. Large commercial poultry and swine industries are under persistent pressure to manage grain and protein costs, use alternative raw materials, maintain feed conversion and reduce nutrient losses. Those pressures align directly with the function of xylanase, β-glucanase, β-mannanase and other NSP-degrading enzymes.

 

Xylanase should remain the largest enzyme category because cereal arabinoxylans give it the broadest substrate base. Poultry is expected to remain the leading application, while swine provides significant expansion potential as producers use more fiber-rich ingredients. Multi-enzyme combinations should gain importance, although future adoption will increasingly depend on evidence that each added enzyme addresses a relevant dietary substrate.

 

China and the United States stand out because they combine enormous feed throughput with large industrial poultry and swine populations. Meanwhile, Brazil, Europe, India and Southeast Asia provide additional demand through different grain and by-product formulations.

 

Non-Starch Polysaccharide Enzymes Market Report Coverage Table

Report Attribute	Details
Market Size Value in 2025	USD 1.18 billion
Revenue Forecast in 2032	USD 1.91 billion
Overall Growth Rate	7.2% CAGR
Forecast Period	2026–2032
Base Year for Estimation	2025
Historical Data	2019-2024
Quantitative Units	USD Million, USD Billion and CAGR (2026–2032)
Report Segmentation	Enzyme Type, Animal Application and Geography
By Enzyme Type	Xylanase, β-Glucanase, β-Mannanase, Cellulase, Pectinase and Multi-Enzyme NSP Systems
By Animal Application	Poultry, Swine and Aquaculture
By Geography	North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Countries Covered	United States, Canada, Mexico, United Kingdom, Germany, France, Italy, Spain, China, Japan, India, South Korea, Indonesia, Australia, Brazil, Argentina, Saudi Arabia, United Arab Emirates and South Africa
Key Companies Profiled	Novonesis, BASF, IFF/Danisco Animal Nutrition & Health, AB Enzymes, AB Vista, Adisseo, Kemin Industries and Huvepharma
Market Drivers	Feed-cost optimization, demand for improved nutrient utilization, growing poultry and swine production, increased use of alternative feed ingredients, expansion of industrial feed production, development of thermostable enzymes and adoption of substrate-specific multi-enzyme systems
Customization Option	Report customization Available